Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

Tyrosinemia type II

MONDO:0010160

Tyrosinemia type 2 is an inborn error of tyrosine metabolism characterized by hypertyrosinemia with oculocutaneous manifestations and, in some cases, intellectual deficit.

Also known as: Richner-Hanhart syndrome, keratosis palmoplantaris-corneal dystrophy syndrome, oculocutaneous tyrosinemia, tyrosinemia due to TAT deficiency, tyrosinemia due to tyrosine aminotransferase deficiency, tyrosinemia type II, Oregon type tyrosinemia, Richner Hanhart syndrome

40 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Metabolic disease (215) Hereditary disease (172) Skin disorder (123) Eye disorder (97) Inborn errors of metabolism (42) Human disease (14) Tyrosinemia (6) Hereditary skin disorder (5) Inborn disorder of amino acid metabolism (4)
Trials to join now! 24 Not yet recruiting 4 Not yet finished but already full! 5 Completed 6 Terminated 1
Sort by
  • VR headsets tested as a possible treatment for blindness

    Disease control Terminated

    This study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…

    Phase: NA • Sponsor: Stanford University • Aim: Disease control

    Last updated Jun 27, 2026 08:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space